Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003

British Journal of Haematology

Volumn 166, Issue 3, 2014, Pages 421-424

  Patrick, Katharine ^a   Wade, Rachel ^b   Goulden, Nick ^c   Mitchell, Chris ^d   Moorman, Anthony V ^e   Rowntree, Clare ^f   Jenkinson, Sarah ^g   Hough, Rachael ^h   Vora, Ajay ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Acute lymphoblastic leukaemia; Child; Early T precursor

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; EARLY T CELL PRECURSOR LYMPHOBLASTIC LEUKEMIA; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL TIME;

ACUTE LYMPHOBLASTIC LEUKAEMIA; CHILD; EARLY T-PRECURSOR;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASM STAGING; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904070404     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12882     Document Type: Article

References (10)

1. Coustan-Smith, E., Mullighan, C.G., Onciu, M., Behm, F.G., Raimondi, S.C., Pei, D., Cheng, C., Su, X., Rubnitz, J.E., Basso, G., Biondi, A., Pui, C.H., Downing, J.R. & Campana, D. (2009) Early T-cell precursor leukemia: a subtype of very high-risk acute lymphoblastic leukemia identified in two independant cohorts. The Lancet Oncology, 10, 147-156.
2. Ma, M., Wang, X., Tang, J., Xue, H., Chen, J., Pan, C., Jiang, H. & Shen, S. (2012) Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia. Frontiers of Medicine, 6, 416-420.
3. Meijerink, J.P.P. (2010) Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia. Best Practice & Research Clinical Haematology, 23, 307-318.
4. Neumann, M., Heesch, S., Gökbuget, N., Schwartz, S., Schlee, C., Benlasfer, O., Farhadi-Sartangi, N., Thibaut, J., Burmeister, T., Hoelzer, D., Hofmann, W.-K., Thiel, E. & Baldus, C.D. (2012) Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations. Blood Cancer Journal, 2, e55.
5. Neumann, M., Coskun, E., Fransecky, L., Mochmann, L.H., Bartram, I., Sartangi, N.F., Heesch, S., Gökbuget, N., Schwartz, S., Brandts, C., Schlee, C., Haas, R., Dührsen, U., Griesshammer, M., Döhner, H., Ehninger, G., Burmeister, T., Blau, O., Thiel, E., Hoelzer, D., Hofmann, W.-K. & Baldus, C.D. (2013) FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors. PLoS ONE, 8, e53190.
6. Van Vlierberghe, P., Ambesi-Impiombato, A., De Keersmaecker, K., Hadler, M., Paietta, E., Tallman, M.S., Rowe, J.M., Forne, C., Rue, M. & Ferrando, A.A. (2013) Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia. Blood, 122, 74-82.
7. Vora, A., Wade, R., Mitchell, C.D., Goulden, N. & Richards, S. (2008) Improved outcome for children and young adults with T-cell acute lymphoblastic leukaemia (ALL): results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003. Blood (ASH Annual Meeting Abstracts), 112, 908.
8. Vora, A., Goulden, N., Wade, R., Mitchell, C., Hancock, J., Hough, R., Rowntree, C. & Richards, S. (2013) Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. The Lancet Oncology, 14, 199-209.
9. Wood, B., Winter, S., Dunsmore, K., Raetz, E., Borowitz, M.J., Devidas, M., Winick, N.J., Carroll, W.L., Hunger, S.P. & Loh, M.L. (2009) Patients with Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia (ALL) have high levels of minimal residual disease (MRD) at the end of induction-A Children's Oncology Group (COG) Study. Blood (ASH Annual Meeting Abstracts), 114, 9.
10. Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S.L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., Lu, C., Chen, S.-C., Wei, L., Collins-Underwood, J.R., Ma, J., Roberts, K.G., Pounds, S.B., Ulyanov, A., Becksfort, J., Gupta, P., Huether, R., Kriwacki, R.W., Parker, M., McGoldrick, D.J., Zhao, D., Alford, D., Espy, S., Bobba, K.C., Song, G., Pei, D., Cheng, C., Roberts, S., Barbato, M.I., Campana, D., Coustan-Smith, E., Shurtleff, S.A., Raimondi, S.C., Kleppe, M., Cools, J., Shimano, K.A., Hermiston, M.L., Doulatov, S., Eppert, K., Laurenti, E., Notta, F., Dick, J.E., Basso, G., Hunger, S.P., Loh, M.L., Devidas, M., Wood, B., Winter, S., Dunsmore, K.P., Fulton, R.S., Fulton, L.L., Hong, X., Harris, C.C., Dooling, D.J., Ochoa, K., Johnson, K.J., Obenauer, J.C., Evans, W.E., Pui, C.-H., Naeve, C.W., Ley, T.J., Mardis, E.R., Wilson, R.K., Downing, J.R. & Mullighan, C.G. (2012) The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature, 481, 157-163.